Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (688505.SS)
CNY 7.83
(2.89%)
CNY 7.83
(2.89%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -1.17 Billion CNY | -1.21% |
| 2022 | -1.16 Billion CNY | 1.11% |
| 2021 | -1.17 Billion CNY | 14.49% |
| 2020 | -1.37 Billion CNY | -226.58% |
| 2019 | -421.7 Million CNY | 3.77% |
| 2018 | -438.22 Million CNY | -33.55% |
| 2017 | -328.14 Million CNY | 16.14% |
| 2016 | -391.28 Million CNY | -21.9% |
| 2015 | -320.99 Million CNY | 3.05% |
| 2014 | -331.09 Million CNY | -16.2% |
| 2013 | -284.92 Million CNY | -796.87% |
| 2012 | -31.76 Million CNY | -0.03% |
| 2011 | -31.75 Million CNY | -83.31% |
| 2010 | -17.32 Million CNY | 22.13% |
| 2009 | -22.24 Million CNY | -774.39% |
| 2008 | 3.29 Million CNY | -79.85% |
| 2007 | 16.37 Million CNY | 167.7% |
| 2006 | -24.18 Million CNY | 51.4% |
| 2005 | -49.75 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -1.03 Billion CNY | 14.44% |
| 2024 Q1 | -1.21 Billion CNY | -3.39% |
| 2024 Q2 | -1.21 Billion CNY | 0.69% |
| 2023 Q4 | -1.17 Billion CNY | -4.73% |
| 2023 FY | -1.17 Billion CNY | -1.21% |
| 2023 Q2 | -1.11 Billion CNY | -45.19% |
| 2023 Q1 | -765.75 Million CNY | 34.24% |
| 2023 Q3 | -1.12 Billion CNY | -1.22% |
| 2022 Q1 | -1.12 Billion CNY | 4.87% |
| 2022 Q2 | -1.17 Billion CNY | -5.15% |
| 2022 Q4 | -1.16 Billion CNY | 3.88% |
| 2022 Q3 | -1.21 Billion CNY | -2.84% |
| 2022 FY | -1.16 Billion CNY | 1.11% |
| 2021 Q1 | -1.34 Billion CNY | 2.49% |
| 2021 FY | -1.17 Billion CNY | 14.49% |
| 2021 Q2 | -1.09 Billion CNY | 18.41% |
| 2021 Q3 | -886.49 Million CNY | 19.09% |
| 2021 Q4 | -1.17 Billion CNY | -32.84% |
| 2020 Q1 | -384.01 Million CNY | 8.94% |
| 2020 Q4 | -1.37 Billion CNY | -5.9% |
| 2020 Q2 | -1.36 Billion CNY | -255.17% |
| 2020 FY | -1.37 Billion CNY | -226.58% |
| 2020 Q3 | -1.3 Billion CNY | 4.65% |
| 2019 FY | -421.7 Million CNY | 3.77% |
| 2019 Q2 | -341.03 Million CNY | -157.98% |
| 2019 Q1 | 588.22 Million CNY | 234.23% |
| 2019 Q4 | -421.7 Million CNY | 0.0% |
| 2018 Q2 | -342.83 Million CNY | 0.0% |
| 2018 FY | -438.22 Million CNY | -33.55% |
| 2018 Q4 | -438.22 Million CNY | 0.0% |
| 2018 Q3 | -438.22 Million CNY | -27.82% |
| 2018 Q1 | -342.83 Million CNY | -4.48% |
| 2017 Q2 | -375.89 Million CNY | 0.0% |
| 2017 Q1 | -375.89 Million CNY | 3.93% |
| 2017 FY | -328.14 Million CNY | 16.14% |
| 2017 Q4 | -328.14 Million CNY | 0.0% |
| 2017 Q3 | -328.14 Million CNY | 12.7% |
| 2016 FY | -391.28 Million CNY | -21.9% |
| 2016 Q4 | -391.28 Million CNY | 0.0% |
| 2016 Q2 | -348.24 Million CNY | 0.0% |
| 2016 Q1 | -348.24 Million CNY | -8.49% |
| 2016 Q3 | -391.28 Million CNY | -12.36% |
| 2015 Q3 | -320.99 Million CNY | -7.7% |
| 2015 FY | -320.99 Million CNY | 3.05% |
| 2015 Q1 | -298.05 Million CNY | 9.98% |
| 2015 Q4 | -320.99 Million CNY | 0.0% |
| 2015 Q2 | -298.05 Million CNY | 0.0% |
| 2014 FY | -331.09 Million CNY | -16.2% |
| 2014 Q3 | -331.09 Million CNY | -27.74% |
| 2014 Q2 | -259.2 Million CNY | 0.0% |
| 2014 Q1 | -259.2 Million CNY | 9.03% |
| 2014 Q4 | -331.09 Million CNY | 0.0% |
| 2013 Q2 | -196 Million CNY | -221.78% |
| 2013 Q4 | -284.92 Million CNY | 0.0% |
| 2013 FY | -284.92 Million CNY | -796.87% |
| 2013 Q1 | 160.94 Million CNY | 606.62% |
| 2012 FY | -31.76 Million CNY | -0.03% |
| 2012 Q2 | -3.09 Million CNY | 0.0% |
| 2012 Q4 | -31.76 Million CNY | 0.0% |
| 2011 FY | -31.75 Million CNY | -83.31% |
| 2011 Q2 | -38.38 Million CNY | 0.0% |
| 2011 Q4 | -31.75 Million CNY | 0.0% |
| 2010 Q4 | -17.32 Million CNY | 0.0% |
| 2010 Q2 | -59.1 Million CNY | 0.0% |
| 2010 FY | -17.32 Million CNY | 22.13% |
| 2009 FY | -22.24 Million CNY | -774.39% |
| 2008 FY | 3.29 Million CNY | -79.85% |
| 2007 FY | 16.37 Million CNY | 167.7% |
| 2006 FY | -24.18 Million CNY | 51.4% |
| 2005 FY | -49.75 Million CNY | 0.0% |